Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | PLK4 | O00444 | 2/20 | 0.44 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.44 |
| ▸ | PRKCG | P05129 | 2/20 | 0.44 |
| ▸ | PIM1 | P11309 | 2/20 | 0.44 |
| ▸ | PHKG2 | P15735 | 2/20 | 0.44 |
| ▸ | CDK2 | P24941 | 2/20 | 0.44 |
| ▸ | AXL | P30530 | 2/20 | 0.44 |
| ▸ | AKT1 | P31749 | 2/20 | 0.44 |
| ▸ | AKT2 | P31751 | 2/20 | 0.44 |
| ▸ | SYK | P43405 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10813682 | 0.83 | HDAC1 (0.44) | HTTLMNAL3MBTL1SMN1; SMN2CNR1 | |
| SCHEMBL5635835 | 0.80 | KCNN4 (0.52) | L3MBTL1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL2845025 | 0.80 | HDAC3 (0.61) | HTTLMNAL3MBTL1SMN1; SMN2CNR1 | |
| SCHEMBL15253649 | 0.79 | AR (0.51) | HTTLMNAL3MBTL1CNR1CNR2 | |
| SCHEMBL4620848 | 0.78 | HTT (0.56) | HTTLMNAL3MBTL1SMN1; SMN2CNR1 | |
| SCHEMBL10815988 | 0.78 | MAPT (0.47) | HTTLMNAL3MBTL1SMN1; SMN2HDAC3 | |
| SCHEMBL21378779 | 0.77 | MAPT (0.61) | CNR1CNR2HDAC3HDAC4HDAC1 | |
| SCHEMBL30594253 | 0.77 | PDK1 (0.55) | HTTLMNAL3MBTL1SMN1; SMN2CNR1 | |
| SCHEMBL8671312 | 0.77 | GAA (0.53) | HTTLMNAL3MBTL1SMN1; SMN2CNR1 | |
| SCHEMBL4377312 | 0.77 | CYP1A2 (0.48) | HTTLMNAL3MBTL1SMN1; SMN2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014080-A1 | LIPOSOMAL PREPARATION WITH ENCAPSULATED HORMONES, METHOD OF PRODUCTION AND USE THEREOF | VAN BOGAERT GINA (BE) | 2026-01-15 | — | — | US | disclosed |
| US-20230248742-A1 | PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE | SLAYBACK PHARMA LLC (US) | 2023-08-10 | — | — | US | disclosed |
| US-11642355-B2 | Pharmaceutical compositions of testosterone | SLAYBACK PHARMA LLC (US) | 2023-05-09 | — | — | US | disclosed |
| US-20220202830-A1 | PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE | SLAYBACK PHARMA LLC (US) | 2022-06-30 | — | — | US | disclosed |
| US-11311554-B2 | Pharmaceutical compositions of testosterone | SLAYBACK PHARMA LLC (US) | 2022-04-26 | — | — | US | disclosed |
| CN-110724124-A | Triazole derivatives | 株式会社半导体能源研究所 | 2020-01-24 | — | — | CN | disclosed |
| US-20190307772-A1 | PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE | SLAYBACK PHARMA LLC (US) | 2019-10-10 | — | — | US | disclosed |
| CN-101542370-A | Fine particle dispersion liquid | NATOCO CO LTD (JP) | 2009-09-23 | — | — | CN | disclosed |
| US-4883907-A | Carbazates | EGIS GYOGYSZERGYAR (HU) | 1989-11-28 | — | — | US | disclosed |
| US-4824670-A | ANIMAL FEEDS | EGIS GYOGYSZERGYAR (HU) | 1989-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248742-A1 | PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE | SHBG, CYP17A1, NR5A1 | HTT 368/4885LMNA 793/4885L3MBTL1 2261/4885 |
| US-11311554-B2 | Pharmaceutical compositions of testosterone | SHBG, CYP17A1, NR5A1 | HTT 419/4885LMNA 828/4885L3MBTL1 2423/4885 |
| US-11642355-B2 | Pharmaceutical compositions of testosterone | SHBG, CYP17A1, NR5A1 | HTT 396/4885LMNA 800/4885L3MBTL1 2328/4885 |
| US-20260014080-A1 | LIPOSOMAL PREPARATION WITH ENCAPSULATED HORMONES, METHOD OF PRODUCTION AND USE THEREOF | NR5A1, SHBG, GNRHR | HTT 1672/4885LMNA 796/4885L3MBTL1 2588/4885 |
| US-20190307772-A1 | PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE | SHBG, CYP17A1, NR5A1 | HTT 419/4885LMNA 828/4885L3MBTL1 2423/4885 |
| US-20220202830-A1 | PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE | SHBG, CYP17A1, NR5A1 | HTT 396/4885LMNA 800/4885L3MBTL1 2328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.